Elliott Robert E, Wisoff Jeffrey H
Department of Neurosurgery, New York University School of Medicine, New York, New York, USA.
J Neurosurg Pediatr. 2010 Nov;6(5):403-16. doi: 10.3171/2010.8.PEDS09385.
Prior work by the authors' group and reports of other authors suggest worse functional outcomes and decreased survival in children with larger craniopharyngiomas. The purpose of this study was to assess the oncological, endocrinological, and functional outcomes in children who underwent radical resection of giant craniopharyngiomas (defined as 5 cm or greater in largest diameter).
Between 1986 and 2006, 26 children under the age of 18 (14 boys, 12 girls; mean age 10.5 years) underwent radical resection of giant craniopharyngiomas performed by the senior author. Data were retrospectively collected to assess the outcome of surgical treatment.
Twenty (77%) of 26 patients underwent gross-total resection (GTR) confirmed by intraoperative inspection and postoperative imaging. All primary tumors (17 of 17) and 3 (33%) of 9 recurrent tumors were treated with GTR. There was no operative mortality, and 18 of 26 patients (69%) were alive at a mean follow-up of 8.9 years (median 9.3 years). Disease control was achieved in 21 (84%) of the 25 patients followed up for more than 6 months and was more successful in patients who underwent GTR (95%) than in those who underwent STR (50%, p = 0.03). New-onset diabetes insipidus (DI) occurred in 63.2% of patients (73% of patients had DI postoperatively). New or worsened deficits in visual acuity and visual fields occurred in 16% and 28%, respectively, of the 25 patients for whom postoperative visual data were available. Five patients (19%) experienced significant, permanent neurological deficits, and 5 (19%) had mild to moderate deficits. New or worsened hypothalamic disturbance occurred in 35% and 22% of patients, respectively, but obesity developed in only 15%.
In this retrospective series, radical resection of giant craniopharyngiomas in children was found to lead to excellent rates of disease control with acceptable or good functional outcomes but slightly higher rates of neurological complications compared with rates in patients with smaller tumors. Radical resection is less successful in recurrent tumors that reach very large sizes, especially previously irradiated tumors, with resultant diminished survival.
作者团队之前的研究工作以及其他作者的报告表明,颅咽管瘤较大的儿童功能预后较差,生存率降低。本研究的目的是评估接受巨大颅咽管瘤(定义为最大直径5厘米或更大)根治性切除术的儿童的肿瘤学、内分泌学和功能预后。
1986年至2006年期间,18岁以下的26名儿童(14名男孩,12名女孩;平均年龄10.5岁)接受了由资深作者进行的巨大颅咽管瘤根治性切除术。回顾性收集数据以评估手术治疗的结果。
26例患者中有20例(77%)经术中检查和术后影像学证实为全切除(GTR)。所有原发性肿瘤(17例中的17例)和9例复发性肿瘤中的3例(33%)接受了GTR治疗。无手术死亡,26例患者中有18例(69%)在平均随访8.9年(中位数9.3年)时存活。在随访超过6个月的25例患者中,21例(84%)实现了疾病控制,接受GTR的患者(95%)比接受次全切除(STR)的患者(50%,p = 0.03)更成功。63.2%的患者出现了新发尿崩症(DI)(73%的患者术后出现DI)。在有术后视力数据的25例患者中,分别有16%和28%的患者出现了新的或恶化的视力和视野缺损。5例患者(19%)出现了严重的永久性神经功能缺损,5例(19%)有轻度至中度缺损。分别有35%和22%的患者出现了新的或恶化的下丘脑功能障碍,但只有15%的患者出现了肥胖。
在这个回顾性系列研究中,发现儿童巨大颅咽管瘤的根治性切除术能带来优异的疾病控制率,功能预后可接受或良好,但与较小肿瘤患者相比,神经并发症发生率略高。对于复发性肿瘤,尤其是之前接受过放疗的非常大的肿瘤,根治性切除术不太成功,导致生存率降低。